Avançar para navegação principal Avançar para pesquisar Avançar para conteúdo principal

Adrenal findings in FDG-PET: analysis of a cohort of 1021 patients from a cancer center

  • Joana Maciel
  • , Daniela Cavaco
  • , Davide Fraga
  • , Sara Donato
  • , Helder Simões
  • , Rita Sousa
  • , Joana Simões-Pereira*
  • *Autor correspondente para este trabalho

Resultado de pesquisa: Contribuição em revista científica › Artigo › revisão de pares

5 Citações (Scopus)

Resumo

Purpose: The use of FDG-PET for cancer staging has led to the increasing incidence of adrenal lesions, which are usually a clinical challenge. We aimed to characterize the adrenal lesions found in FDG-PET of patients followed in a cancer center. Methods: Retrospective analysis was conducted of all FDG-PET studies performed in our center in the last 10 years. Exams reporting adrenal lesions in the CT component and/or anomalous adrenal FDG uptake were selected. Cases were characterized by the clinical, laboratory, imaging, and pathological findings. Results: We identified 27,427 FDG-PET studies. Of those, 7.6% reported adrenal findings. We included 1364 exams corresponding to 1021 patients. Only 15.6% of the patients were referred to the Endocrinology Department and 38% of the lesions were not studied. In 38.9% of the studied patients, malignant lesions were present, including metastases in 37.5%, carcinoma in 1.2%, and other malignant tumors in 0.4%. The median SUVmax of malignant lesions was significantly higher than the SUVmax of the benign findings (p < 0.05). We also observed a higher median SUVmax in adrenal metastases than in adenomas (p < 0.05). There was a tendency for higher SUVmax of adrenal carcinomas when compared with other malignant lesions (p = 0.066). The median SUVmax was not different between pheochromocytomas and other tumors (p > 0.05). Conclusion: Occult adrenal lesions discovered during FDG-PET/CT are common in the cancer context and are frequently benign. SUVmax may be a useful tool in the workup of adrenal lesions but with several important caveats.

Idioma originalInglês
Páginas (de-até)131-138
Número de páginas8
RevistaHormones
Volume22
Número de emissão1
DOIs
Estado da publicaçãoPublicado - mar. 2023
Publicado externamenteSim

ODS da ONU

Este resultado contribui para o(s) seguinte(s) Objetivo(s) de Desenvolvimento Sustentável

  1. ODS 3 - Saúde de Qualidade
    ODS 3 Saúde de Qualidade

Impressão digital

Mergulhe nos tópicos de investigação de “Adrenal findings in FDG-PET: analysis of a cohort of 1021 patients from a cancer center“. Em conjunto formam uma impressão digital única.

Citação